Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleophosmin 1 pseudogene 33 (NPM1P33) is a *processed pseudogene* related to the nucleophosmin 1 (NPM1) gene family. **Pseudogenes** are DNA sequences similar to normal genes but contain mutations or truncations that prevent them from encoding functional proteins. NPM1P33 does not produce an active nucleophosmin (NPM1) protein and is not known to play a direct role in cell function or pathology. Unlike the protein-coding NPM1 gene—which is involved in ribosome biogenesis, chromatin remodeling, and is an oncogenic driver in acute myeloid leukemia—NPM1P33 has no established biological function or disease association in the scientific literature[1]. Therefore, it should not be considered a therapeutic target or functional molecule in pharmacology or molecular biology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleophosmin 1 pseudogene 33 (NPM1P33).